XML 23 R28.htm IDEA: XBRL DOCUMENT v2.4.0.8
Fair Value Measurements (Details) (USD $)
6 Months Ended 3 Months Ended 6 Months Ended
Jun. 30, 2014
Dec. 31, 2013
Jun. 30, 2013
Jun. 30, 2013
Sarepta Therapeutics, Inc. [Member]
Jun. 30, 2013
Regulus Therapeutics Inc. [Member]
Jun. 30, 2014
Achaogen Inc [Member]
Jun. 30, 2014
2 3/4 percent convertible senior notes [Member]
Dec. 31, 2013
2 3/4 percent convertible senior notes [Member]
Jun. 30, 2014
Recurring basis [Member]
Dec. 31, 2013
Recurring basis [Member]
Jun. 30, 2014
Recurring basis [Member]
Corporate debt securities [Member]
Dec. 31, 2013
Recurring basis [Member]
Corporate debt securities [Member]
Jun. 30, 2014
Recurring basis [Member]
Debt securities issued by U.S. government agencies [Member]
Dec. 31, 2013
Recurring basis [Member]
Debt securities issued by U.S. government agencies [Member]
Jun. 30, 2014
Recurring basis [Member]
Debt securities issued by the U.S. Treasury [Member]
Dec. 31, 2013
Recurring basis [Member]
Debt securities issued by the U.S. Treasury [Member]
Jun. 30, 2014
Recurring basis [Member]
Debt securities issued by states of the United States and political subdivisions of the states [Member]
Dec. 31, 2013
Recurring basis [Member]
Debt securities issued by states of the United States and political subdivisions of the states [Member]
Jun. 30, 2014
Recurring basis [Member]
Equity securities [Member]
Dec. 31, 2013
Recurring basis [Member]
Equity securities [Member]
Jun. 30, 2014
Recurring basis [Member]
Quoted Prices in Active Markets (Level 1) [Member]
Dec. 31, 2013
Recurring basis [Member]
Quoted Prices in Active Markets (Level 1) [Member]
Jun. 30, 2014
Recurring basis [Member]
Quoted Prices in Active Markets (Level 1) [Member]
Corporate debt securities [Member]
Dec. 31, 2013
Recurring basis [Member]
Quoted Prices in Active Markets (Level 1) [Member]
Corporate debt securities [Member]
Jun. 30, 2014
Recurring basis [Member]
Quoted Prices in Active Markets (Level 1) [Member]
Debt securities issued by U.S. government agencies [Member]
Dec. 31, 2013
Recurring basis [Member]
Quoted Prices in Active Markets (Level 1) [Member]
Debt securities issued by U.S. government agencies [Member]
Jun. 30, 2014
Recurring basis [Member]
Quoted Prices in Active Markets (Level 1) [Member]
Debt securities issued by the U.S. Treasury [Member]
Dec. 31, 2013
Recurring basis [Member]
Quoted Prices in Active Markets (Level 1) [Member]
Debt securities issued by the U.S. Treasury [Member]
Jun. 30, 2014
Recurring basis [Member]
Quoted Prices in Active Markets (Level 1) [Member]
Debt securities issued by states of the United States and political subdivisions of the states [Member]
Dec. 31, 2013
Recurring basis [Member]
Quoted Prices in Active Markets (Level 1) [Member]
Debt securities issued by states of the United States and political subdivisions of the states [Member]
Jun. 30, 2014
Recurring basis [Member]
Quoted Prices in Active Markets (Level 1) [Member]
Equity securities [Member]
Dec. 31, 2013
Recurring basis [Member]
Quoted Prices in Active Markets (Level 1) [Member]
Equity securities [Member]
Jun. 30, 2014
Recurring basis [Member]
Significant Other Observable Inputs (Level 2) [Member]
Dec. 31, 2013
Recurring basis [Member]
Significant Other Observable Inputs (Level 2) [Member]
Jun. 30, 2014
Recurring basis [Member]
Significant Other Observable Inputs (Level 2) [Member]
Corporate debt securities [Member]
Dec. 31, 2013
Recurring basis [Member]
Significant Other Observable Inputs (Level 2) [Member]
Corporate debt securities [Member]
Jun. 30, 2014
Recurring basis [Member]
Significant Other Observable Inputs (Level 2) [Member]
Debt securities issued by U.S. government agencies [Member]
Dec. 31, 2013
Recurring basis [Member]
Significant Other Observable Inputs (Level 2) [Member]
Debt securities issued by U.S. government agencies [Member]
Jun. 30, 2014
Recurring basis [Member]
Significant Other Observable Inputs (Level 2) [Member]
Debt securities issued by the U.S. Treasury [Member]
Dec. 31, 2013
Recurring basis [Member]
Significant Other Observable Inputs (Level 2) [Member]
Debt securities issued by the U.S. Treasury [Member]
Jun. 30, 2014
Recurring basis [Member]
Significant Other Observable Inputs (Level 2) [Member]
Debt securities issued by states of the United States and political subdivisions of the states [Member]
Dec. 31, 2013
Recurring basis [Member]
Significant Other Observable Inputs (Level 2) [Member]
Debt securities issued by states of the United States and political subdivisions of the states [Member]
Jun. 30, 2014
Recurring basis [Member]
Significant Other Observable Inputs (Level 2) [Member]
Equity securities [Member]
Dec. 31, 2013
Recurring basis [Member]
Significant Other Observable Inputs (Level 2) [Member]
Equity securities [Member]
Jun. 30, 2014
Recurring basis [Member]
Significant Unobservable Inputs (Level 3) [Member]
Dec. 31, 2013
Recurring basis [Member]
Significant Unobservable Inputs (Level 3) [Member]
Jun. 30, 2014
Recurring basis [Member]
Significant Unobservable Inputs (Level 3) [Member]
Corporate debt securities [Member]
Dec. 31, 2013
Recurring basis [Member]
Significant Unobservable Inputs (Level 3) [Member]
Corporate debt securities [Member]
Jun. 30, 2014
Recurring basis [Member]
Significant Unobservable Inputs (Level 3) [Member]
Debt securities issued by U.S. government agencies [Member]
Dec. 31, 2013
Recurring basis [Member]
Significant Unobservable Inputs (Level 3) [Member]
Debt securities issued by U.S. government agencies [Member]
Jun. 30, 2014
Recurring basis [Member]
Significant Unobservable Inputs (Level 3) [Member]
Debt securities issued by the U.S. Treasury [Member]
Dec. 31, 2013
Recurring basis [Member]
Significant Unobservable Inputs (Level 3) [Member]
Debt securities issued by the U.S. Treasury [Member]
Jun. 30, 2014
Recurring basis [Member]
Significant Unobservable Inputs (Level 3) [Member]
Debt securities issued by states of the United States and political subdivisions of the states [Member]
Dec. 31, 2013
Recurring basis [Member]
Significant Unobservable Inputs (Level 3) [Member]
Debt securities issued by states of the United States and political subdivisions of the states [Member]
Jun. 30, 2014
Recurring basis [Member]
Significant Unobservable Inputs (Level 3) [Member]
Equity securities [Member]
Dec. 31, 2013
Recurring basis [Member]
Significant Unobservable Inputs (Level 3) [Member]
Equity securities [Member]
Fair Value Measurements [Abstract]                                                                                                                
Amount of transfer between Level 1 and Level 2 investments $ 0   $ 0                                                                                                          
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]                                                                                                                
Cash equivalents                 70,638,000 [1] 133,233,000 [1]                     70,638,000 [1] 133,233,000 [1]                     0 [1] 0 [1]                     0 [1] 0 [1]                    
Available-for-sale securities                     339,847,000 [1],[2] 407,897,000 [1],[2] 98,373,000 [2] 64,432,000 [2] 11,264,000 [2] 15,328,000 [2] 66,391,000 [2] 22,255,000 [2] 2,481,000 [3] 1,276,000 [3]     0 [1],[2] 0 [1],[2] 0 [2] 0 [2] 11,264,000 [2] 15,328,000 [2] 0 [2] 0 [2] 625,000 [3] 1,276,000 [3]     339,847,000 [1],[2] 407,897,000 [1],[2] 98,373,000 [2] 64,432,000 [2] 0 [2] 0 [2] 66,391,000 [2] 22,255,000 [2] 0 [3] 0 [3]     0 [1],[2] 0 [1],[2] 0 [2] 0 [2] 0 [2] 0 [2] 0 [2] 0 [2] 1,856,000 [3] 0 [3]
Investment in Regulus Therapeutics Inc. 56,678,000 52,096,000             56,678,000 52,096,000                     56,678,000 52,096,000                     0 0                     0 0                    
Total assets                 645,672,000 696,517,000                     139,205,000 201,933,000                     504,611,000 494,584,000                     1,856,000 0                    
Realized gain on sale of common stock       1,100,000                                                                                                        
Gross fair value of investment         69,200,000 2,100,000                                                                                                    
Lack of marketability discount         7,000,000 214,000                                                                                                    
Interest rate on convertible debt (in hundredths) 2.75% 2.75%         2.75% 2.75%                                                                                                
Fair value of convertible notes             $ 448,300,000                                                                                                  
[1] Included in cash and cash equivalents on our condensed consolidated balance sheet.
[2] Included in short-term investments on our condensed consolidated balance sheet.
[3] Included in other current assets on our condensed consolidated balance sheet.